Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeometals Regulatory News (NMT)

Share Price Information for Neometals (NMT)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £26.93m
NMT Live PriceLast checked at - London Stock Exchange

Intraday Neometals Share Chart

Successful ELi Purification Pilot Trial

10 Nov 2023 07:00

RNS Number : 0142T
Neometals Ltd
10 November 2023
 

This announcement contains inside information

 

10 November 2023

 

Neometals Ltd

("Neometals" or "the Company")

 

Successful ELi Purification Pilot Trial

 

Highlights:

· Neometals 70% owned lithium chemical processing technology ("ELi?") purifies lithium chloride to specification required for electrolysis trial to commence;

· Pilot trials are being co-funded by Bondalti group, whilst a new co-operation agreement is being negotiated to cover proposed Demonstration Plant in Portugal.

· ELi? has several advantages over conventional processes including lower operating expenditures by substituting electricity for chemical reagents, higher product purity and a smaller CO2 footprint.

 

Innovative battery materials recycler, Neometals Ltd (ASX: NMT & AIM: NMT) ("Neometals" or "the Company"), is pleased to announce successful completion of the purification phase ("Purification Testwork") of its Lithium Chemical pilot trial ("Pilot"). The Purification Testwork, conducted on a brine feed source, has confirmed earlier bench-scale testing by removing >97% of brine feed source impurities. This supports production of a purified brine solution that sits comfortably within specification for subsequent electrolysis stage of the Company's majority owned ELi? process ("ELi? Technology").

Neometals' Lithium Chemical business unit is commercialising the ELi? Technology owned by Reed Advanced Materials Pty Ltd ("RAM") (70% NMT, 30% Mineral Resources Ltd (ASX:MIN)). RAM is co-funding the Pilot with Bondalti group, Portugal's largest chlor-alkali chemical producer and held by José de Mello Group, one of Portugal's largest corporate groups.

The ELi? process comprises brine purification, followed by electrolysis where electricity is used to convert lithium chloride solutions into lithium hydroxide and/or lithium carbonate. The purification Pilot, undertaken by a third party laboratory, processed an actual South American salar brine concentrate.

The pilot has confirmed earlier bench-scale testing and successfully removed from the brine the impurities that are impediments to optimum electrolysis performance. Brine analysis "before" (unpurified brine feed) and "after" (purified brine) is summarised as follows:

Table 1 - Assay Results before and after Purification

(mg/L)

Li

Ca

Mg

B

Sr

Si

Before

62,654

6,260

15,792

7,141

71

52

After (ave)

45,100

1

% removed*

n/a

>99.98

>99.99

>99.99

>99.99

>97

*Using the assay detection limit for calculation of recovery

ELi? has several advantages over conventional processes including lower operating expenditures by substituting electricity for chemical reagents, higher product purity and a smaller CO2 footprint. The Purification Testwork successfully removed impurities that can impede electrolysis efficiency (consumption). Higher and stable electrical current efficiency in turn extends electrolysis membrane durability (useful life), reducing maintenance time and cost and increasing the end-product grade.

Figure 1: Schematic showing a comparison of the conventional flowsheet forthe production of lithium hydroxide from brines with the Eli? process

Next steps

The schedule for next stage activities is as follows:

Activity

Location

Completion

Purified brine delivery

Vancouver

Q4 23

Brine and test preparation

Buffalo

Q4 23

Split sample for electrolysis pilot

Buffalo

Q4 23

Full-scale test

Vancouver

Q4 23

Long-term electrolysis pilot

Buffalo

Q1 24

Lithium hydroxide crystallisation

Buffalo

Q1 24

 

Background - Lithium Refinery("LR") Project

With the original planned pilot activities nearing conclusion and Bondalti's parent incorporating a dedicated lithium subsidiary, Lifthium Energy S.A., RAM and Bondalti Group are continuing to co-fund the agreed pilot plant activities while a new cooperation agreement is being negotiated in parallel[1]. The evaluation activities completion of an engineering cost study ("LR ECS") and pilot-scale metallurgical test-work ("Pilot Trials").

Table 2: Key LR ECS Metrics*

ECS Metrics (100% ownership basis)

Annual Production

25,000tpa LHM

Annual Throughput

80,000 tpa Brine @ 6% Li

Average Operating Cost (±15%)**

?1,768/t (US$1,945/t) LHM

Total initial capital costs (±15%)***

?405M (US$446 M)

Capital Intensity****

?16,200/t (US$17,840/t) LHM capacity

 

* (for full details refer to Neometals ASX announcement headlined 'Portugal Lithium Refinery Study Confirms Step-change Opex of ELiTM Technology" released on 26th April 2023).

** from receipt of 6% Li brine concentrate to packaged high purity "battery grade" lithium hydroxide product, excluding by-product credits

*** Total of direct and indirect capex including 15% contingency, EPC fees and design post-Class 3

**** Based on total capex and 25,000tpa LHM capacity

 

 

 

Figure 2: Engineering Cost Study Opex comparison showing significantly reduced operating costs to generate LHM when compared to conventional Brine and spodumene routes (noting that conventional Brine processing is a two-stage process with lithium carbonate ("LC") produced before additional processing into LHM.

 

Authorised on behalf of Neometals by Christopher Reed, Managing Director.

 

For more information, please contact:

 

Neometals Ltd

Chris Reed, Managing Director & Chief Executive Officer

 +61 8 9322 1182

Jeremy McManus, General Manager - IP & IR

 +61 8 9322 1182

 

Cavendish Securities plc - NOMAD & Joint Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

RBC Capital Markets - Joint Broker

+44 (0) 20 7653 4000

Paul Betts

Jamil Miah

Camarco PR

+ 44(0) 20 3 757 4980

Gordon Poole

Emily Hall

Lily Pettifar

 

About Neometals

Neometals has developed and is commercialising three environmentally-friendly processing technologies that produce critical and strategic battery materials at lowest quartile costs with minimal carbon footprint.

Through strong industry partnerships, Neometals is demonstrating the economic and environmental benefits of sustainably producing lithium, nickel, cobalt and vanadium from lithium-ion battery recycling and steel waste recovery. This reduces the reliance on traditional mine-based supply chains and creating more resilient, circular supply to support the energy transition. 

The Company's three core business units are exploiting the technologies under principal, joint venture and licensing business models:

 

· Lithium-ion Battery ("LiB") Recycling (50% technology) - Commercialisation via Primobius GmbH JV (NMT 50% equity). All plants built by Primobius' co-owner (SMS group 50% equity), a 150-year-old German plant builder. Providing recycling service as principal in Germany and commenced plant supply and licensing activities as technology partner to Mercedes-Benz. Primobius targeting first commercial 21,000 tpa plant offer to Canadian company Stelco in the DecQ 2023;

· Lithium Chemicals (70% technology) - Commercialising patented ELi? electrolysis process, co-owned 30% by Mineral Resources Ltd, to produce battery quality lithium hydroxide from brine and/or hard-rock feedstocks at lowest quartile operating costs. Co-funding Pilot Plant trials in 2023 with planned Demonstration Plant trials and evaluation studies in 2024 for potential 25,000tpa LiOH operation in Portugal under a 50:50 JV with related entity to Bondalti, Portugal's largest chemical company; and

· Vanadium Recovery (100% technology) - aiming to produce high-purity vanadium pentoxide from processing of steelmaking by-product ("Slag") at lowest-quartile operating cost. Targeting partnerships with steel makers and participants in the vanadium chemical value chain under a low risk / low capex technology licensing business model.

 

For further information visit www.neometals.com.au

 

 


1 (for full details refer to Neometals ASX announcement headlined "Lithium Chemicals Co-operation Update" released on 3rd October 2023).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKCBDBBDBFDK
Date   Source Headline
3rd Feb 20257:00 amRNSCancellation - Neometals Ltd
23rd Jan 20257:01 amRNSQuarterly Activities Report
23rd Jan 20257:01 amRNSQuarterly Cashflow
17th Jan 20257:00 amRNSCancellation of Performance Rights
20th Dec 20247:00 amRNSProposed Cancellation of Admission to AIM
6th Dec 20247:00 amRNSDirector/PDMR Dealings
22nd Nov 20249:09 amRNSResult of Annual General Meeting
22nd Nov 20247:42 amRNSChairman’s AGM 2024 Address
18th Nov 20241:14 pmRNS2024 Annual General Meeting Broadcast
12th Nov 20247:00 amRNSPositive Results from ELi™ Pilot Trial
8th Nov 20249:24 amRNSDirector / PDMR Participation in Entitlement Offer
7th Nov 202410:16 amRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSResults of Entitlement Offer
24th Oct 20247:01 amRNSQuarterly Activities Report
24th Oct 20247:01 amRNSQuarterly Cashflow
22nd Oct 20247:00 amRNSMercedes Benz Plant Opening
21st Oct 20247:00 amRNSNotice of Annual General Meeting
21st Oct 20247:00 amRNSEntitlement Offer Opens
18th Oct 20247:00 amRNSDirector/PDMR Dealings
14th Oct 20249:49 amRNSPosting of Annual Report
11th Oct 20247:00 amRNSA$4 Million Placement and Entitlement Offer
9th Oct 20247:00 amRNSASX Trading Halt
30th Sep 20247:50 amRNSResult of EGM
26th Sep 20248:56 amRNSAnnual Financial Report
23rd Sep 20247:00 amRNSBarrambie Gold Exploration Target
20th Sep 20247:00 amRNSAGM Update
16th Sep 20247:00 amRNSVRP receives EU supported capital injection
27th Aug 202410:02 amRNSNotice of EGM
22nd Aug 20247:00 amRNSPrecious Metals Recovery Option Lapse
22nd Aug 20247:00 amRNSNeometals Strategy Update
19th Aug 20247:00 amRNSUS$3M Placement
16th Aug 20247:00 amRNSResults of Extraordinary General Meeting
7th Aug 20247:00 amRNSCorporate Presentation
30th Jul 20247:19 amRNSQuarterly Activities Report
30th Jul 20247:15 amRNSQuarterly Cashflow
17th Jul 20248:36 amRNSNotice of Extraordinary General Meeting
11th Jul 20247:12 amRNSAppointment of Company Secretary
9th Jul 20249:59 amRNSDirector/PDMR Dealings
4th Jul 202411:59 amRNSIssue of Shares
27th Jun 202410:26 amRNSDirector Change
6th Jun 20248:34 amRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSPrecious Metals Due Diligence Update
3rd Jun 20247:00 amRNSAppointment of Chief Financial Officer
29th May 20247:00 amRNSNeometals Strengthens its Senior Management Team
28th May 20247:00 amRNSOption to acquire Precious Metals Process & Plant
22nd May 20247:00 amRNSFinal Stage of ELi™ Pilot Trial Commences
15th May 202412:38 pmRNSNeometals Shares Commence Trading on OTCQX market
24th Apr 20247:01 amRNSQuarterly Cashflow Report
24th Apr 20247:00 amRNSQuarterly Activities Report
18th Apr 202410:24 amRNSChange in Substantial Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.